Abstract

Chondrogenic differentiation by mesenchymal progenitor cells (MPCs) is associated with cytokines such as transforming growth factor-beta 1 (TGF-β1) and dexamethasone. Extracellular matrix (ECM) also regulates the differentiation by MPCs. To define whether ECM plays a functional role in regulation of the chondrogenic differentiation by MPCs, an in vitro model was used. That model exposed to dexamethasone, recombinant human TGF-β1(rhTGF-β1) and collagens. The results showed that MPCs incorporated with dexamethasone and rhTGF-β1 increased proliferation and expression of glycosaminoglycan (GAG) after 14 days. Type II collagen enhanced the GAG synthesis, but did not increase alkaline phosphatase (ALP) activity. When adding dexamethasone and rhTGF-β1 MPCs increased mRNA expression of Sox9. Incorporation with type II collagen, dexamethasone and rhTGF-β1, MPCs induced mRNA expression of aggrecan and enhanced levels of type II collagen, and Sox9 mRNA. In contrast, incorporation with type I collagen, dexamethasone and rhTGF-β1 MPCs reduced levels of aggrecan, and Sox9 mRNA, and showed no type II collagen mRNA. Altogether, these results indicate that type I and II collagen, in addition to the cytokine effect, may play a functional role in regulating of chondrogenic differentiation by MPCs.

Original languageEnglish
Pages (from-to)446-453
Number of pages8
JournalJournal of Orthopaedic Research
Volume23
Issue number2
DOIs
Publication statusPublished - Mar 2005

Fingerprint

Collagen Type II
Collagen Type I
Mesenchymal Stromal Cells
Dexamethasone
Messenger RNA
Aggrecans
Glycosaminoglycans
Transforming Growth Factor beta
Extracellular Matrix
Cytokines
Alkaline Phosphatase
Collagen

Keywords

  • Chondrogenic differentiation
  • Collagen
  • Dexamethasone
  • Extracellular matrix
  • Mesenchymal progenitor cells
  • TGF-beta;1

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Type I and II collagen regulation of chondrogenic differentiation by mesenchymal progenitor cells. / Chen, C. W.; Tsai, Yu-Hui; Deng, W. P.; Shih, S. N.; Fang, C. L.; Burch, J. G.; Chen, W. H.; Lai, Wen-FuThomas.

In: Journal of Orthopaedic Research, Vol. 23, No. 2, 03.2005, p. 446-453.

Research output: Contribution to journalArticle

Chen, C. W. ; Tsai, Yu-Hui ; Deng, W. P. ; Shih, S. N. ; Fang, C. L. ; Burch, J. G. ; Chen, W. H. ; Lai, Wen-FuThomas. / Type I and II collagen regulation of chondrogenic differentiation by mesenchymal progenitor cells. In: Journal of Orthopaedic Research. 2005 ; Vol. 23, No. 2. pp. 446-453.
@article{b8fef8ca08604876bc579c02a54e9e2c,
title = "Type I and II collagen regulation of chondrogenic differentiation by mesenchymal progenitor cells",
abstract = "Chondrogenic differentiation by mesenchymal progenitor cells (MPCs) is associated with cytokines such as transforming growth factor-beta 1 (TGF-β1) and dexamethasone. Extracellular matrix (ECM) also regulates the differentiation by MPCs. To define whether ECM plays a functional role in regulation of the chondrogenic differentiation by MPCs, an in vitro model was used. That model exposed to dexamethasone, recombinant human TGF-β1(rhTGF-β1) and collagens. The results showed that MPCs incorporated with dexamethasone and rhTGF-β1 increased proliferation and expression of glycosaminoglycan (GAG) after 14 days. Type II collagen enhanced the GAG synthesis, but did not increase alkaline phosphatase (ALP) activity. When adding dexamethasone and rhTGF-β1 MPCs increased mRNA expression of Sox9. Incorporation with type II collagen, dexamethasone and rhTGF-β1, MPCs induced mRNA expression of aggrecan and enhanced levels of type II collagen, and Sox9 mRNA. In contrast, incorporation with type I collagen, dexamethasone and rhTGF-β1 MPCs reduced levels of aggrecan, and Sox9 mRNA, and showed no type II collagen mRNA. Altogether, these results indicate that type I and II collagen, in addition to the cytokine effect, may play a functional role in regulating of chondrogenic differentiation by MPCs.",
keywords = "Chondrogenic differentiation, Collagen, Dexamethasone, Extracellular matrix, Mesenchymal progenitor cells, TGF-beta;1",
author = "Chen, {C. W.} and Yu-Hui Tsai and Deng, {W. P.} and Shih, {S. N.} and Fang, {C. L.} and Burch, {J. G.} and Chen, {W. H.} and Wen-FuThomas Lai",
year = "2005",
month = "3",
doi = "10.1016/j.orthres.2004.09.002",
language = "English",
volume = "23",
pages = "446--453",
journal = "Journal of Orthopaedic Research",
issn = "0736-0266",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Type I and II collagen regulation of chondrogenic differentiation by mesenchymal progenitor cells

AU - Chen, C. W.

AU - Tsai, Yu-Hui

AU - Deng, W. P.

AU - Shih, S. N.

AU - Fang, C. L.

AU - Burch, J. G.

AU - Chen, W. H.

AU - Lai, Wen-FuThomas

PY - 2005/3

Y1 - 2005/3

N2 - Chondrogenic differentiation by mesenchymal progenitor cells (MPCs) is associated with cytokines such as transforming growth factor-beta 1 (TGF-β1) and dexamethasone. Extracellular matrix (ECM) also regulates the differentiation by MPCs. To define whether ECM plays a functional role in regulation of the chondrogenic differentiation by MPCs, an in vitro model was used. That model exposed to dexamethasone, recombinant human TGF-β1(rhTGF-β1) and collagens. The results showed that MPCs incorporated with dexamethasone and rhTGF-β1 increased proliferation and expression of glycosaminoglycan (GAG) after 14 days. Type II collagen enhanced the GAG synthesis, but did not increase alkaline phosphatase (ALP) activity. When adding dexamethasone and rhTGF-β1 MPCs increased mRNA expression of Sox9. Incorporation with type II collagen, dexamethasone and rhTGF-β1, MPCs induced mRNA expression of aggrecan and enhanced levels of type II collagen, and Sox9 mRNA. In contrast, incorporation with type I collagen, dexamethasone and rhTGF-β1 MPCs reduced levels of aggrecan, and Sox9 mRNA, and showed no type II collagen mRNA. Altogether, these results indicate that type I and II collagen, in addition to the cytokine effect, may play a functional role in regulating of chondrogenic differentiation by MPCs.

AB - Chondrogenic differentiation by mesenchymal progenitor cells (MPCs) is associated with cytokines such as transforming growth factor-beta 1 (TGF-β1) and dexamethasone. Extracellular matrix (ECM) also regulates the differentiation by MPCs. To define whether ECM plays a functional role in regulation of the chondrogenic differentiation by MPCs, an in vitro model was used. That model exposed to dexamethasone, recombinant human TGF-β1(rhTGF-β1) and collagens. The results showed that MPCs incorporated with dexamethasone and rhTGF-β1 increased proliferation and expression of glycosaminoglycan (GAG) after 14 days. Type II collagen enhanced the GAG synthesis, but did not increase alkaline phosphatase (ALP) activity. When adding dexamethasone and rhTGF-β1 MPCs increased mRNA expression of Sox9. Incorporation with type II collagen, dexamethasone and rhTGF-β1, MPCs induced mRNA expression of aggrecan and enhanced levels of type II collagen, and Sox9 mRNA. In contrast, incorporation with type I collagen, dexamethasone and rhTGF-β1 MPCs reduced levels of aggrecan, and Sox9 mRNA, and showed no type II collagen mRNA. Altogether, these results indicate that type I and II collagen, in addition to the cytokine effect, may play a functional role in regulating of chondrogenic differentiation by MPCs.

KW - Chondrogenic differentiation

KW - Collagen

KW - Dexamethasone

KW - Extracellular matrix

KW - Mesenchymal progenitor cells

KW - TGF-beta;1

UR - http://www.scopus.com/inward/record.url?scp=14244252412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14244252412&partnerID=8YFLogxK

U2 - 10.1016/j.orthres.2004.09.002

DO - 10.1016/j.orthres.2004.09.002

M3 - Article

C2 - 15734261

AN - SCOPUS:14244252412

VL - 23

SP - 446

EP - 453

JO - Journal of Orthopaedic Research

JF - Journal of Orthopaedic Research

SN - 0736-0266

IS - 2

ER -